论文部分内容阅读
本文总结１９９１年８月至１９９６年４月应用溶栓及ＰＴＣＡ治疗ＡＭＩ９２例，男７６例，女１６例，年龄４６～７０岁之间，平均年龄６０．２±１０．５岁。治疗分为：①冠状动脉内输注尿激酶（ＩＣＵＫ）组３２例；②静脉输注尿激酶（ＩＶＵＫ）组４１例；③经皮冠状动脉腔内成形（ＰＴＣＡ）组１９例。全组再通６９例，总再通率为７５．０％，ＩＣＵＫ组、ＩＶＵＫ组、ＰＴＣＡ组再通率分别为７５．０％、６５．７％和９４．７％三组再通率比较有显著差异。三组患者近期预后比较：全组９２例，死亡９例，死亡率９．７８％，８例发生于梗塞血管未通者，１例发生于血管再通者。ＩＣＵＫ组３２例，死亡３例（９．３７％），发生心功能不全８例（２５．０％）；ＩＶＵＫ组４１例，死亡５例（１２．０％），发生心功能不全１１例（２６．８３％）；ＰＴＣＡ组１９例，死亡１例，死亡率为５．２６％，ＰＴＣＡ组无心功能不全者。
This article summarizes the application of thrombolysis and PTCA in 92 cases of AMI from August 1991 to April 1996, 76 males and 16 females, aged 46 to 70 years old with an average age of 60.2 ± 10.5 years. The treatment was divided into: ① coronary artery infusion of urokinase (ICUK) group of 32 patients; ② intravenous infusion of urokinase (IVUK) group of 41 patients; ③ percutaneous transluminal coronary angioplasty (PTCA) group of 19 patients. The whole group recanalization in 69 cases, the total recanalization rate was 75.0%, ICUK group, IVUK group, PTCA group recanalization rates were 75.0%, 65.7% and 94.7% of the three groups recanalization rate comparison There are significant differences. The recent prognosis of three groups of patients compared: 92 cases of the whole group, 9 cases of death, the mortality rate was 9.78%, 8 cases occurred in patients with infarction, one case occurred in patients with recanalization. There were 32 cases in ICUK group, 3 deaths (9.37%), 8 cases (25.0%) with cardiac insufficiency, 41 cases in IVUK group, 5 deaths (12.0%) and 11 cases of cardiac insufficiency 26.83%); PTCA group 19 cases, 1 died, the mortality rate was 5.26%, PTCA group without cardiac insufficiency.